Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous to Patients With CKD

NCT01213992 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-dialysis Dependent Chronic Kidney Disease

Interventions

DRUG: Iron isomaltoside 1000
DRUG: Iron isomaltoside 1000

Sponsor

Pharmacosmos A/S